Nonspecific bronchial responsiveness to methacholine chloride was assessed by an astograph in 20 non-smoking, non-atopic and non-steroid-treated patients with sarcoidosis, 43 asthmatics and 20 normal subjects. Before the study, baseline pulmonary function tests and serum angiotensin-converting enzyme level were measured.
1) In patients with sarcoidosis, Dmin (bronchial sensitivity) was significantly reduced compared to normal subjects (p<0.01), and bronchial hyperresponsiveness to methacholine was observed.
2) No significant correlation was observed between Dmin and duration of disease, and no significant difference in Dmin was observed between chest X-ray type 1 and chest X-ray types II and III.
3) No significant correlations were observed between Dmin and baseline pulmonary function tests (%VC, FEV
1.0%, %MMF, %V
50, %V
25, %ΔV
50, %ΔV
25, %Visv) in patients with sarcoidosis.
4) Significant correlation was observed between Dmin and serum angiotensin-converting enzyme levels in patients with sarcoidosis (p<0.02).
5) Bronchofiberscopic findings of inflammation (capillary dilatation and/or redness of bronchial mucosa) were more frequent in responders (Dmin<50unit) than nonresponders (Dmin≥50 unit) in patients with sarcoidosis.
These results suggest that bronchial hyperresponsiveness to methacholine in patients with sarcoidosis is related to bronchial mucosal inflammatory changes with active sarcoidosis lesions.
View full abstract